Skip to main content

Table 1 Advantages and disadvantages of gene editing tools

From: Gene therapy for cystic fibrosis: new tools for precision medicine

 

ZFN

TALEN

CRISPR/Cas9

Base Editing

Prime editing

Mechanism

Type IIs restriction enzyme, FokI endonuclease, fused to pair of ZFN DNA binding domains

Recognize 18-36 bp of DNA sequence

Target DNA sequence break by protein-DNA interaction

Type IIs restriction enzyme, FokI endonuclease, fused to pair of TALEN DNA binding domains

Recognize 30-40 bp of DNA sequence

Target DNA sequence break by protein-DNA interaction

Few Cas endonuclease options for broader specificity and flexibility (Cas9, Cas12)

PAM sequence require to design sgRNA

Target DNA sequence break by DNA-RNA interaction

Direct conversion of a DNA base to another without DSBs at a target locus

Permanent conversion of C-G to T-A base pairs by cytosin base editor (CBEs)

Enzymatically convert A-T base pairs into G-C base pairs by adenine base editors (ABEs)

Fusion complex composed of a catalytically impaired Cas9 protein and an engineered reverse transcriptase

Can recognize DNA of any sequence size

Efficiency

Low

Low

High

High

High

Advantages

Currently being used in clinical trials for HIV and Hunter’s syndrome

Low immunity and Small protein size

Target any DNA sequence

Less cytotoxic effects

Highly predictable target sequence

Easy to design and possible to target only 1 bp of target sequence

Potentially target multiple genes simultaneously

No random insertion and deletions because do not require DNA break

High A > G and C > T conversion

No random insertion and deletions because do not require DNA break

Can be used to generate different mutation types (insertions, deletions, and point mutations)

Limitations

Difficult due to extensive cloning needed to link two zinc finger modules together and expensive to design

Sensitive to DNA methylation

Require pair of TALEN with two independent DNA binding sites

Require PAM site near the target DNA sequence to design gRNA

Off-target effect observed

Cas9 protein too large for AAV-based delivery

Only accounts for 4 out of 12 possible base-to-base conversions

Too large for AAV-based delivery

Difficult to edit DNA sequence that several A or C residues are nearby

High targeting efficiency but may depend on cell type

Too large for AAV-based delivery

Detection of undesired off-target effects and on-target mutation